Unique VOC technology combined with deep learning enables, in its simplicity, early detection of ovarian cancer through smell in a blood sample.
Latest news
SOLUTION
We are further developing our product and collecting clinical evidence to obtain regulatory approval in the European market targeted to be introduced to the market 2026.
ADVANCING CANCER DIAGNOSTICS
Our mission is to enable a paradigm shift in early diagnosis of ovarian cancer through unmatched performance regarding sensitivity and specificity.
UNIQUE SOLUTION
VOC Diagnostics has developed a unique detection method by analyzing volatile organic compounds from blood plasma samples to detect ovarian cancer with higher accuracy than any other available method.
COLLABORATE
We welcome partnerships with academia to explore clinical applications across indications.
We welcome interest from investors and are happy to provide more information on VOC Diagnostics’ plans for development and commercialization on request.
